NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
$36.40
-0.25%
-0.09
Notify me if price changes either direction
Buy NAMS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.1B
Enterprise value
3.4B
Trailing PE
-14.218750596046
Forward PE
-19.25926
PEG Ratio
0.22801878006857
Enterprise to EBITDA
-19.47
Enterprise to revenue
52.508
Price to book MRQ
5.260876
Price to sales TTM
64.05143
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-06-30
Revenue (TTM)
64.0M
EBITDA
-172616000
Diluted EPS TTM
-1.59
Total Cash (MRQ)
739.2M
Current ratio (MRQ)
21.085
Operating Cash Flow (TTM)
-124122000
NAMS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
October 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
